Poly Medicure Ltd Q2 FY26 Earnings Analysis

Published 4 Aug 2026 | Healthcare Equipment & Supplies | Market Cap: ₹15.3K Cr

Price

1,728

Market Cap

₹15.3K Cr

P/E Ratio

43.5

Earnings Summary

No information is provided regarding the same in the latest conference call. No information is provided regarding the same in the latest conference call.

📊 Revenue & Sales Performance

No information is provided regarding the same in the latest conference call.

📈 Profitability & Margins

No information is provided regarding the same in the latest conference call.

🏗️ Capital Expenditure Plans

No information is provided regarding the same in the latest conference call.

💰 Fundraising & Capital Structure

No information is provided regarding the same in the latest conference call.

📋 Order Book & Pipeline

No information is provided regarding the same in the latest conference call.

Key Metrics

Frequently Asked Questions

What were Poly Medicure Ltd Q2 FY26 results?

No information is provided regarding the same in the latest conference call. No information is provided regarding the same in the latest conference call.

What is Poly Medicure Ltd share price analysis?

Poly Medicure Ltd currently shows a neutral. The stock trades at a P/E of 43.5 with a market cap of ₹15,327. Investors should review the full earnings analysis for detailed insights.

Is Poly Medicure Ltd planning capital expenditure?

No information is provided regarding the same in the latest conference call.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

Others in Healthcare Equipment & Supplies this season

  • Tarsons Products Ltd (Q2 FY26)

    Tarsons Products Ltd Q2 FY26 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹1,101, P/E 51.